Vaccine against Covid-19

Area of intervention “Health, pandemics and One Health” Developing vaccine production capacity

In order to achieve a more just distribution of COVID-19 vaccines across the globe, Germany supports COVAX, the international vaccine initiative. The German government also provides support for the development of production capacity worldwide, focusing on South Africa, Ghana and Senegal. So far, only a very small proportion of the vaccines used in Africa has been produced locally.

The BMZ is providing a 50 million euro package to support South African partners’ efforts to develop local production capacity. Funding is being provided for improving vaccine logistics and cold chain management, and for strengthening regulatory and certification organisations. Training activities and support for research are being offered to enable South Africa to develop other vaccines as well.

Moreover, together with other donors, the Deutsche Investitions- und Entwicklungsgesellschaft (DEG) has contributed to financing for Aspen, a South African company that has produced the Johnson & Johnson vector vaccine under licence since April 2021. This will enable the company to increase production from 300 million to 600 million doses a year.

As at: 25/08/2023